MGP and neoplasm: As shown in Fig. 5A, a dramatic reduction in tumor initiation was observed upon ablation of MGP: at 100 days post-injection, 10 out of 10 mice with OVCAR3-CTR cells developed tumors, while no tumors were observed in the MGP-knockout group.